Promising peptide slows the spread and growth of melanoma in mice

Promising peptide slows the spread and growth of melanoma in mice

Publication date: May 24, 2022

The treatment also increased group survival by more than 25 percent. The researchers also note that no side effects were seen in the treated mice. Melanoma is the deadliest form of skin cancer, thanks to its ability to rapidly spread to other organs. Tumor growth was delayed by up to 40 days in the treated mice, and significantly reduced the number of metastatic nodules found in the animals lungs.

Concepts Keywords
Biotech Skin cancer
Cancer Metastasis
Cultured Melanocytic nevus
Deadliest Uveal melanoma
Mice DecisionDx-UM
Cancer
Causes of death
Neoplasms
Melanoma

Semantics

Type Source Name
disease MESH metastasis
disease MESH cancer
disease MESH skin cancer
pathway KEGG Melanoma
disease MESH melanoma
disease MESH growth

Original Article

Leave a Comment

Your email address will not be published.